MTOR and breast cancer: In the present study, we took the approach to assess transcriptional alterations in response to inhibition of PI3K/mTOR/p70S6K pathway in breast cancer cell lines with known gene copy number and gene expression alterations, since RPS6KB1 encoding p70S6K is one of the most highly amplified and overexpressed genes in breast cancer.